 |
|
|
| |
Machine Learning Models of Non-invasive Tests to Predict MASH and Fibrosis Stage
Based on MAESTRO-NAFLD-1 and MAESTRO-NASH Liver Biopsies
|
| |
| |
EASL 2026 May 26-30 Barcelona
Rohit Loomba1, Rebecca Taub2, Dominic Labriola2, Jan Priel3, Krishna Padmanabhan2, W. Ray Kim4
1University of California at San Diego, La Jolla, CA, United States, 2Madrigal Pharmaceuticals, Inc., West Conshohocken, PA, United States, 3Cytel, Inc., Cambridge, MA, United States
4Mayo Clinic College of Medicine and Science, Phoenix, AZ, United States
|
| |
|
|
|
|
|
